AUD 0.08
(-3.53%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 1.51 Million AUD | -80.26% |
2023 | 7.69 Million AUD | -8.8% |
2022 | 8.43 Million AUD | 174.87% |
2021 | 3.06 Million AUD | 16.02% |
2020 | 2.64 Million AUD | -57.53% |
2019 | 6.22 Million AUD | -26.27% |
2018 | 8.44 Million AUD | 445.29% |
2017 | 1.54 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.94 Million AUD | 0.0% |
2024 Q4 | 1.51 Million AUD | 0.0% |
2024 FY | 1.51 Million AUD | -80.26% |
2023 FY | 7.69 Million AUD | -8.8% |
2023 Q2 | 10.04 Million AUD | 0.0% |
2023 Q4 | 7.69 Million AUD | 0.0% |
2022 Q4 | 8.43 Million AUD | 0.0% |
2022 FY | 8.43 Million AUD | 174.87% |
2022 Q2 | 6.36 Million AUD | 0.0% |
2021 Q2 | 6.81 Million AUD | 0.0% |
2021 FY | 3.06 Million AUD | 16.02% |
2021 Q4 | 3.06 Million AUD | 0.0% |
2020 Q4 | 2.64 Million AUD | 0.0% |
2020 FY | 2.64 Million AUD | -57.53% |
2020 Q2 | 4.49 Million AUD | 0.0% |
2019 Q4 | 6.22 Million AUD | 0.0% |
2019 Q2 | 7.29 Million AUD | 0.0% |
2019 FY | 6.22 Million AUD | -26.27% |
2018 Q4 | 8.44 Million AUD | 0.0% |
2018 FY | 8.44 Million AUD | 445.29% |
2018 Q2 | 9.44 Million AUD | 0.0% |
2017 FY | 1.54 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Australian Clinical Labs Limited | 593.06 Million AUD | 99.744% |
BCAL Diagnostics Limited | 12.26 Million AUD | 87.618% |
Genetic Signatures Limited | 67.28 Million AUD | 97.743% |
Genetic Technologies Limited | 6.18 Million AUD | 75.451% |
Healius Limited | 2.98 Billion AUD | 99.949% |
Imagion Biosystems Limited | 4.58 Million AUD | 66.886% |
Integral Diagnostics Limited | 744.27 Million AUD | 99.796% |
INOVIQ Ltd | 21.7 Million AUD | 93.003% |
Microba Life Sciences Limited | 58.04 Million AUD | 97.383% |
Monash IVF Group Limited | 508.47 Million AUD | 99.701% |
Sonic Healthcare Limited | 14.82 Billion AUD | 99.99% |